Healthy Volunteer Study of Clopidogrel and Rifampicin

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Coronary Artery Disease
Interventions
DRUG

Clopidogrel and Rifampicin

"Clopidogrel: loading dose of 600 mg, then 75 mg o.d. for up to 28 days~Rifampicin: 300 mg b.d. for up to 28 days"

Trial Locations (1)

S10 2JF

Sheffield Clinical Research Facility, Royal Hallamshire Hospital, Sheffield

All Listed Sponsors
collaborator

British Heart Foundation

OTHER

collaborator

University of Sheffield

OTHER

lead

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

NCT00696566 - Healthy Volunteer Study of Clopidogrel and Rifampicin | Biotech Hunter | Biotech Hunter